Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Phibro Animal HealthPAHC -3.41%75 PB Ratio is 3.84 as of Aug. 08, 2026, which is 11% below its 10-year median of 4.30. GuruFocus rates PAHC with a GF Score™ of 75/100 and a GF Value™ of $29.54 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 921 Drug Manufacturers companies, Phibro Animal Health ranks worse than 75.68% on this metric.
The historical rank and industry rank for Phibro Animal Health's PB Ratio or its related term are showing as below:
PAHC'
s PB Ratio Range Over the Past 10 Years
Min: 1.43 Med: 4.3 Max: 11.86
Current: 3.84
During the past 13 years, Phibro Animal Health's highest PB Ratio was 11.86. The lowest was 1.43. And the median was 4.30.
PAHC's PB Ratio is ranked worse than 75.68% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.96
vs PAHC: 3.84
During the past 12 months, Phibro Animal Health's average Book Value Per Share Growth Rate was 35.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 17.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Phibro Animal Health was 113.20% per year. The lowest was 2.50% per year. And the median was 8.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Phibro Animal Health PB Ratio Related Terms
Phibro Animal Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Phibro Animal Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phibro Animal Health PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Phibro Animal Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Phibro Animal Health (PAHC) has a PB Ratio of 3.84 as of Aug. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Phibro Animal Health and its competitors. This is 11% below median its historical median of 4.30. Over the past decade, Phibro Animal Health's PB Ratio has ranged from 1.43 to 11.86. According to the industry distribution chart, Phibro Animal Health ranks #697 out of 921 companies in the Drug Manufacturers industry, placing it in the top 75.7%.
Is Phibro Animal Health's PB Ratio too high?
Phibro Animal Health's current PB Ratio of 3.84 is 11% below median its 10-year median of 4.30. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 11.86. The Drug Manufacturers industry median PB Ratio is 1.96. Phibro Animal Health's value of 3.84 is 95.9% above this industry median. Based on the distribution chart, Phibro Animal Health ranks #697 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Phibro Animal Health has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Phibro Animal Health's PB Ratio compare to PRGO and HROW?
According to the Drug Manufacturers industry distribution chart, Phibro Animal Health ranks #697 out of 921 companies for PB Ratio. This places Phibro Animal Health in the lower half of its industry. The industry median PB Ratio is 1.96. Phibro Animal Health's value of 3.84 is 95.9% above this benchmark. Historically, Phibro Animal Health's own PB Ratio has ranged from 1.43 to 11.86 over the past decade. While the company's 10-year median is 4.30 vs. the industry median of 1.96, Phibro Animal Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.96, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phibro Animal Health's current PB Ratio of 3.84 is 95.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Phibro Animal Health and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phibro Animal Health's current PB Ratio is 3.84, which is 11% below median its own 10-year median of 4.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phibro Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Phibro Animal Health (PAHC) is currently considered Modestly Overvalued. The stock's GF Value™ is $29.54, compared to a current price of $34.26 — trading 16% above its estimated fair value. The current PB Ratio is 3.84, which is 11% below median its 10-year median of 4.30 and 95.9% above the Drug Manufacturers industry median of 1.96. Phibro Animal Health's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Phibro Animal Health (PAHC), the current PB Ratio is 3.84 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phibro Animal Health (PAHC) Overvalued in 2026?
Based on GuruFocus' analysis, Phibro Animal Health stock appears to be overvalued.
The current stock price of $34.26 is trading 16% above its estimated GF Value™ of $29.54.
GuruFocus considers Phibro Animal Health to be Modestly Overvalued.
Key valuation signals for PAHC:
PB Ratio: 3.84 (11% below median its 10-year median of 4.30)
GF Value™: $29.54 vs. price of $34.26 (16% above fair value)
Industry Position: 95.9% above the Drug Manufacturers median (#697 of 921)
No single metric tells the full story. See the PAHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
75GF Score
Get the complete analysis for PAHC
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PAHC has been successfully added to your 
